Scott Henry
Stock Analyst at Alliance Global Partners
(1.24)
# 3,719
Out of 5,135 analysts
60
Total ratings
37.74%
Success rate
-6.17%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.84 | +256.29% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $0.91 | +313.72% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $1.62 | +270.37% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $9.33 | +7.18% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $11.87 | +247.51% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $8.42 | +0.95% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.00 | +300.32% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $3.45 | +334.78% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.26 | +4,605.88% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $5.85 | +28.21% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.48 | +37.13% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $30.15 | -20.40% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $189.94 | -52.62% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $24.29 | -36.19% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $90.75 | -36.09% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $101.44 | -64.51% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.38 | +697.10% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.85 | +55.84% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $0.86 | +669,283.00% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.14 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.78 | +795.14% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $15.08 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.43 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.84
Upside: +256.29%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $0.91
Upside: +313.72%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $1.62
Upside: +270.37%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $9.33
Upside: +7.18%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $11.87
Upside: +247.51%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $8.42
Upside: +0.95%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.00
Upside: +300.32%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $3.45
Upside: +334.78%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.26
Upside: +4,605.88%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $5.85
Upside: +28.21%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $9.48
Upside: +37.13%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $30.15
Upside: -20.40%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $189.94
Upside: -52.62%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $24.29
Upside: -36.19%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $90.75
Upside: -36.09%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $101.44
Upside: -64.51%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.38
Upside: +697.10%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.85
Upside: +55.84%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $0.86
Upside: +669,283.00%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.14
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.78
Upside: +795.14%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $15.08
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.43
Upside: -